header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-PUB-130918-16
Transcriptome Profiling Reveals Th17-Like Immune Responses Induced in Zebrafish Bath-Vaccinated with a Live Attenuated Vibrio anguillarum
Zhang, H., Fei, C., Wu, H., Yang, M., Liu, Q., Wang, Q., and Zhang, Y.
Date: 2013
Source: PLoS One 8(9): e73871 (Journal)
Registered Authors: Liu, Qin
Keywords: none
MeSH Terms:
  • Adaptive Immunity/genetics
  • Animals
  • Bacterial Vaccines/immunology*
  • Cytokines/genetics
  • Gene Expression Profiling*
  • Receptors, Cell Surface/genetics
  • Signal Transduction/genetics
  • Th17 Cells/immunology*
  • Transcription Factors/genetics
  • Vaccination*
  • Vaccines, Attenuated/immunology
  • Vibrio/immunology*
  • Zebrafish/genetics*
  • Zebrafish/immunology*
PubMed: 24023910 Full text @ PLoS One
ABSTRACT

Background

A candidate vaccine, live attenuated Vibrio anguillarum developed in our laboratory could prevent vibriosis of fish resulted from V. anguillarum and V. alginolyticus. To elucidate the molecular mechanisms underlying the vaccine protection, we used microarray technology to compare the spleen transcriptomes of bath-vaccinated and unvaccinated zebrafish at 28 days post vaccination.

Principal Findings

A total of 2164 genes and transcripts were differentially expressed, accounting for 4.9% of all genes represented on the chip. In addition to iron metabolism related to the innate immunity and the signaling pathways, these differentially expressed genes also involved in the adaptive immunity, mainly including the genes associated with B and T cells activation, proliferation and expansion. Transcription profiles of Th17-related transcription factors, cytokines and cytokine receptors during 35 days post-vaccination implied that Th17 cells be activated in bath-vaccinated zebrafish.

Conclusion/Significance

The transcriptome profiling with microarray revealed the Th17-like immune response to bath-vaccination with the live attenuated V. anguillarum in zebrafish.

ADDITIONAL INFORMATION